| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |